UnitedHealth Group Incorporated (NYSE:UNH) is Scholtz & Company LLC's 7th Largest Position

Scholtz & Company LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,506 shares of the healthcare conglomerate's stock after selling 875 shares during the period. UnitedHealth Group comprises 5.0% of Scholtz & Company LLC's holdings, making the stock its 7th largest holding. Scholtz & Company LLC's holdings in UnitedHealth Group were worth $10,373,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. State Street Corp boosted its position in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after buying an additional 563,554 shares during the period. Geode Capital Management LLC increased its stake in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the period. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $6,375,744,000. Franklin Resources Inc. increased its stake in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after buying an additional 861,854 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in UnitedHealth Group by 0.5% in the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock valued at $4,012,218,000 after buying an additional 36,394 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Remove Ads

UnitedHealth Group Stock Performance

UNH traded up $17.67 during trading on Thursday, reaching $540.87. 6,448,352 shares of the company's stock were exchanged, compared to its average volume of 4,243,984. The stock has a market capitalization of $494.74 billion, a P/E ratio of 34.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company's fifty day simple moving average is $509.15 and its 200-day simple moving average is $542.83. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Finally, Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.